Gori Mauro, Senni Michele, Gupta Deepak K, Charytan David M, Kraigher-Krainer Elisabeth, Pieske Burkert, Claggett Brian, Shah Amil M, Santos Angela B S, Zile Michael R, Voors Adriaan A, McMurray John J V, Packer Milton, Bransford Toni, Lefkowitz Martin, Solomon Scott D
Division of Cardiovascular Medicine, Brigham and Women's Hospital, 75 Francis St, Boston 02445, MA, USA.
Cardiovascular Department, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Eur Heart J. 2014 Dec 21;35(48):3442-51. doi: 10.1093/eurheartj/ehu254. Epub 2014 Jun 30.
Renal dysfunction is a common comorbidity in patients with heart failure and preserved ejection fraction (HFpEF). We sought to determine whether renal dysfunction was associated with measures of cardiovascular structure/function in patients with HFpEF.
We studied 217 participants from the PARAMOUNT study with HFpEF who had echocardiography and measures of kidney function. We evaluated the relationships between renal dysfunction [estimated glomerular filtration rate (eGFR) >30 and <60 mL/min/1.73 m(2) and/or albuminuria] and cardiovascular structure/function.
The mean age of the study population was 71 years, 55% were women, 94% hypertensive, and 40% diabetic. Impairment of at least one parameter of kidney function was present in 62% of patients (16% only albuminuria, 23% only low eGFR, 23% both). Renal dysfunction was associated with abnormal LV geometry (defined as concentric hypertrophy, or eccentric hypertrophy, or concentric remodelling) (adjusted P = 0.048), lower midwall fractional shortening (MWFS) (P = 0.009), and higher NT-proBNP (P = 0.006). Compared with patients without renal dysfunction, those with low eGFR and no albuminuria had a higher prevalence of abnormal LV geometry (P = 0.032) and lower MWFS (P < 0.01), as opposed to those with only albuminuria. Conversely, albuminuria alone was associated with greater LV dimensions (P < 0.05). Patients with combined renal impairment had mixed abnormalities (higher LV wall thicknesses, NT-proBNP; lower MWFS).
Renal dysfunction, as determined by both eGFR and albuminuria, is highly prevalent in HFpEF, and associated with cardiac remodelling and subtle systolic dysfunction. The observed differences in cardiac structure/function between each type of renal damage suggest that both parameters of kidney function might play a distinct role in HFpEF.
肾功能不全是射血分数保留的心力衰竭(HFpEF)患者常见的合并症。我们试图确定肾功能不全是否与HFpEF患者的心血管结构/功能指标相关。
我们研究了PARAMOUNT研究中217例患有HFpEF且接受过超声心动图检查和肾功能检测的参与者。我们评估了肾功能不全[估计肾小球滤过率(eGFR)>30且<60 mL/min/1.73 m²和/或蛋白尿]与心血管结构/功能之间的关系。
研究人群的平均年龄为71岁,55%为女性,94%患有高血压,40%患有糖尿病。62%的患者存在至少一项肾功能参数受损(16%仅为蛋白尿,23%仅为低eGFR,23%两者皆有)。肾功能不全与左心室几何形态异常(定义为向心性肥厚、离心性肥厚或向心性重塑)相关(校正P = 0.048),中壁缩短分数(MWFS)较低(P = 0.009),N末端脑钠肽前体(NT-proBNP)较高(P = 0.006)。与无肾功能不全的患者相比,eGFR低且无蛋白尿的患者左心室几何形态异常的患病率更高(P = 0.032),MWFS更低(P < 0.01),而仅患有蛋白尿的患者则相反。相反,仅蛋白尿与更大的左心室尺寸相关(P < 0.05)。合并肾功能损害的患者存在混合异常(左心室壁厚度、NT-proBNP更高;MWFS更低)。
由eGFR和蛋白尿共同确定的肾功能不全在HFpEF中非常普遍,并与心脏重塑和轻微的收缩功能障碍相关。每种类型的肾脏损害在心脏结构/功能方面观察到的差异表明,肾功能的两个参数在HFpEF中可能发挥不同的作用。